| Drug name |
Drug type |
Disease/phenotype |
Mechanism of action(MoA) |
Phase |
Status |
Source |
| GLESATINIB | Small molecule | non-small cell lung carcinoma | Macrophage-stimulating protein receptor inhibitor | 2.0 | Completed | ClinicalTrials |
| GLESATINIB | Small molecule | non-small cell lung carcinoma | Macrophage-stimulating protein receptor inhibitor | 1.0 | Terminated | ClinicalTrials |
| NARNATUMAB | Antibody | cancer | Macrophage-stimulating protein receptor inhibitor | 1.0 | Completed | ClinicalTrials |
| MK-8033 | Small molecule | cancer | Macrophage-stimulating protein receptor inhibitor | 1.0 | Completed | ClinicalTrials |
| GLESATINIB | Small molecule | cancer | Macrophage-stimulating protein receptor inhibitor | 1.0 | Completed | ClinicalTrials |